BU-NOT-SET

CONTACT US
Optimising excipient selection
  • Drug product
Eyes
Insight
Serialisation stragglers: Industry concern for complacency
  • Manufacturing
Eyes
Insight
The race against the serialisation deadline
  • Manufacturing
Eyes
Insight
Why tomorrow is too late to start your serialisation preparations
  • Manufacturing
Eyes
Insight
The serialisation landscape: Challenges and opportunities for a CDMO
  • Manufacturing
Eyes
Insight
Aseptic manufacturing trends roundtable
  • Industry trends
Eyes
Insight
Developing a high throughput screening method
  • Drug substance
Eyes
Insight
Why outsourcing is key to bringing flexibility and capacity to the manufacture of oral solid dosage forms
  • Manufacturing
Eyes
Insight
Can bigger be better?
  • Industry trends
Eyes
Insight
Case study
  • Drug product
Optimising formulation to improve solubility ready for Phase III
Insight
  • Drug product
  • Industry trends
Trends emerging in capsule dosage form development
Fact sheet
  • Corporate
Licensing portfolio
Insight
  • Industry trends
Key trends in pharmaceutical outsourcing
Insight
  • Drug product
  • Industry trends
The latest trends and innovations in oral drug delivery
Insight
  • Corporate
Recipharm invests in African vaccine production
Insight
  • Drug product
  • Industry trends
The future of oral solid dose development and manufacturing
Report
  • Sustainability
Sustainability Report 2021
Insight
  • Corporate
Treating long-COVID with Erdosteine